CAR-T cell therapies are becoming established as an important treatment modality for cancer. Following the approval by the FDA in 2017, five additional CAR-T therapies have been approved.
CAR-T cell therapies are becoming established as an important treatment modality for cancer. Following the approval by the FDA in 2017, five additional CAR-T therapies have been approved.